NeuBase Therapeutics, Inc. Registration of securities issued in business combination transactions

Registration of securities issued in business combination transactions

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND GOING CONCERN (Policies)
Notes Tables
Notes Details

SUBSEQUENT EVENTS (Details Narrative)

v3.19.1

SUBSEQUENT EVENTS (Details Narrative) - USD ($)		3 Months Ended
SUBSEQUENT EVENTS (Details Narrative) - USD ($)	Jan. 02, 2019	Mar. 31, 2019
Ownership allocation after merger of Company's common stock		8.90%
NeuBaseTherapuetics, Inc. \| Dr. Jason Slakter [Member]
Retention bonus amount	$ 75,000
Subsequent Event [Member]
Ownership allocation after merger of Company's common stock	20.00%
Percent increase (decrease) in ownership allocation for excess proceeds	(0.10%)
Subsequent Event [Member] \| NeuBaseTherapuetics, Inc.
Ownership allocation after merger of Company's common stock	80.00%
Percent increase (decrease) in ownership allocation for excess proceeds	0.10%
Termination fee of merger agreement	$ 250,000
Subsequent Event [Member] \| NeuBaseTherapuetics, Inc. \| Dr. Jason Slakter [Member]
Retention bonus amount	75,000
Subsequent Event [Member] \| NeuBaseTherapuetics, Inc. \| Minimum [Member]
Amount of entity's equity securities to be issued or sold prior to merger	4,000,000
Excess proceeds of minimum amount of equity securities to be issued or sold prior to merger	$ 100,000

- Definition

Amount that entity may issue and sell of its equity securities (including securities convertible,exercisable or exchangeable into such equity securities) prior to the effective time of the Merger.

+ References

No definition available.

+ Details

Name:	ohrp_AmountOfEntitysEquitySecuritiesToBeIssuedOrSoldPriorToMerger
Namespace Prefix:	ohrp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The ownership interest in the merged entity after all transactions have been completed.

+ References

No definition available.

+ Details

Name:	ohrp_CumulativePercentageOwnershipAfterMerger
Namespace Prefix:	ohrp_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of excess proceeds that exceed minimum amount of equity securities to be sold or issued prior to merger.

+ References

No definition available.

+ Details

Name:	ohrp_ExcessProceedsOfMinimumAmountOfEquitySecuritiesToBeIssuedOrSoldPriorToMerger
Namespace Prefix:	ohrp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The increase (decrease) in ownership allocation percent for excess proceeds as defined in merger agreement.

+ References

No definition available.

+ Details

Name:	ohrp_PercentIncreaseDecreaseInOwnershipAllocationForExcessProceeds
Namespace Prefix:	ohrp_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of retention bonus resulting from contractual terms due to merger agreement.

+ References

No definition available.

+ Details

Name:	ohrp_RetentionBonusAmount
Namespace Prefix:	ohrp_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The amount of termination fee that may be required to be paid to NeuBase under merger agreement.

+ References

No definition available.

+ Details

Name:	ohrp_TerminationFeeOfMergerAgreement
Namespace Prefix:	ohrp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_BusinessAcquisitionAxis=ohrp_NeuBaseTherapueticsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ChiefExecutiveOfficerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: